Vol 73, No 1 (2022)
Clinical vignette
Published online: 2022-02-14

open access

Page views 5360
Article views/downloads 421
Get Citation

Connect on Social Media

Connect on Social Media

Sequential therapies in gastric gastrinoma

Violetta Rosiek1
Pubmed: 35381105
Endokrynol Pol 2022;73(1):171-172.

Abstract

Not required for Clinical Vignette.

Article available in PDF format

View PDF Download PDF file

References

  1. Okamoto T, Yoshimoto T, Ohike N, et al. Spontaneous regression of gastric gastrinoma after resection of metastases to the lesser omentum: A case report and review of literature. World J Gastroenterol. 2021; 27(1): 129–142.
  2. Rossi RE, Elvevi A, Citterio D, et al. Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies. World J Gastroenterol. 2021; 27(35): 5890–5907.
  3. Cingam SR, Botejue M, Hoilat GJ. Gastrinoma. StatPearls, Treasure Island 2021.
  4. Lipiński M, Rydzewska G, Foltyn W, et al. Nowotwory neuroendokrynne żołądka i dwunastnicy z uwzględnieniem gastrinoma (zasady postępowania rekomendowane przez Polską Sieć Guzów Neuroendokrynnych). Endokrynol Pol. 2017; 68(2): 138–153.
  5. Pavel M, Öberg K, Falconi M, et al. ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020; 31(7): 844–860.